Evidence map›Paper›PMID 28821315›Full record

Trial reportNutrition research (New York, N.Y.)2017

Starch-entrapped microsphere fibers improve bowel habit but do not exhibit prebiotic capacity in those with unsatisfactory bowel habits: a phase I, randomized, double-blind, controlled human trial.

Heather E Rasmussen, Bruce Hamaker, Kumar B Rajan, Ece Mutlu, Stefan J Green, Michael Brown, Amandeep Kaur, Ali Keshavarzian

Registry-linked trialOpen access · greenAbstract readClinical Trial, Phase IRandomized Controlled Trial
In one paragraph

Trial report in Nutrition research (New York, N.Y.), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01210625 (A Randomized, Double Blind, Controlled, Dose Ranging Trial to Compare Nutrabiotix Fiber to Psyllium Fiber in Patients Experiencing Constipation.), which is not on this map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.6field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01210625 no longer availablenot on this map

A Randomized, Double Blind, Controlled, Dose Ranging Trial to Compare Nutrabiotix Fiber to Psyllium Fiber in Patients Experiencing Constipation.

Typeexpanded_accessSponsorRush University Medical CenterConditionsConstipationArmsNutrabiotix, Psyllium
3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 12 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Heather E RasmussenDepartment of Clinical Nutrition, Rush University Medical Center, 1700 W VanBuren St Ste 425, Chicago, IL, USA 60612. Electronic address: Heather_Rasmussen@rush.edu.
Bruce HamakerDepartment of Food Science, Purdue University, 745 Agriculture Mall Dr, West Lafayette, IN, USA 47907. Electronic address: hamakerb@purdue.edu.
Kumar B RajanRush Institute for Healthy Aging, Department of Internal Medicine, Rush University Medical Center, 1653 W Congress Pkwy, Chicago, IL, USA 60612. Electronic address: Kumar_Rajan@rush.edu.
Ece MutluDivision of Digestive Diseases and Nutrition, Department of Internal Medicine, Rush University Medical Center, 1725 W Harrison St Ste 206, Chicago, IL, USA, 60612. Electronic address: Ece_Mutlu@rush.edu.
Stefan J GreenDNA Services Facility, Research Resources Center, 35 S Wolcott Ave STE E102, University of Illinois, Chicago, IL, USA 60612. Electronic address: greendna@uic.edu.
Michael BrownDivision of Digestive Diseases and Nutrition, Department of Internal Medicine, Rush University Medical Center, 1725 W Harrison St Ste 206, Chicago, IL, USA, 60612. Electronic address: Michael_Brown@rush.edu.
Amandeep KaurDepartment of Food Science, Purdue University, 745 Agriculture Mall Dr, West Lafayette, IN, USA 47907. Electronic address: kaur1@purdue.edu.
Ali KeshavarzianDivision of Digestive Diseases and Nutrition, Department of Internal Medicine, Rush University Medical Center, 1725 W Harrison St Ste 206, Chicago, IL, USA, 60612. Electronic address: Ali_Keshavarzian@rush.edu.
Rush University Medical Center · USPurdue University West Lafayette · USUniversity of Illinois Chicago · US

Funding

Use of a Novel Prebiotic Fiber for Targeted Dietary Management of Irritable BowelR44DK088525 · NIDDK · NUTRABIOTIX, LLC · PI CISNEROS, MARK · 2013 to 2014
$2.6M
Starch-Entrapped Microspheres [Nutrabiotix Fiber] for Gut HealthR43DK088525 · NIDDK · NUTRABIOTIX, LLC · PI CISNEROS, MARK · 2010 to 2010
$248k
NIDDK NIH HHS R43 DK088525NIDDK NIH HHS R44 DK088525
6 · The paper itself

Abstract

Approximately one-third of individuals in the United States experience unsatisfactory bowel habits, and dietary intake, especially one low in fiber, could be partly responsible. We hypothesized that intake of a fermentable fiber (starch-entrapped microspheres, SM) that has a delayed, slow fermentation profile in vitro would improve bowel habit while exhibiting prebiotic capacity in those with self-described unsatisfactory bowel habits, all with minimal adverse effects. A total of 43 healthy volunteers completed a 3-month, double-blind, parallel-arm randomized clinical trial to assess the ability of a daily dose (9 or 12 g) of SM vs psyllium (12 g) to improve bowel habit, including stool consistency and frequency, and modify gut milieu through changes in stool microbiota and short-chain fatty acids while remaining tolerable through minimal gastrointestinal symptoms. All outcomes were compared before and after fiber treatment. Stool frequency significantly improved (P=.0003) in all groups after 3 months, but stool consistency improved only in both SM groups compared with psyllium. In addition, all groups self-reported a similar improvement in overall bowel habit with fiber intake. Both SM and psyllium resulted in minimal changes in microbiota composition and short-chain fatty acid concentrations. The present study suggests that supplementation with a delayed and slow-fermenting fiber in vitro may improve bowel habit in those with constipation, but further investigation is warranted to determine capacity to alter microbiota and fermentation profiles in humans. This trial was registered at ClinicalTrials.gov as NCT01210625.

Indexed as

DefecationMicrospheresAdultConstipationDietDietary FiberDouble-Blind MethodFatty Acids, VolatileFecesFemaleFermentationGastrointestinal MicrobiomeGastrointestinal TractHumansMaleMiddle AgedDietary FiberFatty Acids, VolatilePrebioticsStarchClinical trialConstipationDietary fiberMicrobiotaPrebiotics

Identifiers

PMID28821315
PMCPMC5580357
OpenAlexW2621184184

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.